Kevzara - supply shortage

Resolved

sarilumab

Shortage information

The shortage affecting Kevzara has been resolved and the information and recommendations which were issued during the shortage no longer apply.

Key facts

• Medicines affected:
  Kevzara
• Supply shortage status:
  Resolved
• International non-proprietary name (INN) or common name:
  sarilumab
• Therapeutic area (MESH):
  Arthritis, Rheumatoid
• Pharmaceutical forms affected:
  • Pre-filled syringe
  • Pre-filled pen
  • Solution for subcutaneous injection
• Strengths affected:
  • 150 mg
  • 200 mg
• Availability of alternatives:
  Yes

Key dates

• First published:
  09/11/2021
• Last updated:
  14/09/2023